🇬🇧 AZN.L — AstraZeneca PLC

Healthcare Compra
← Volver

Precio actual

12.006,00 GBp

Máx. histórico

15.732,00

198 días

Caída desde máximo

-23,68%

Rango 52 semanas

9.892,00 – 15.732,00

Variación hoy

-1,15%

Cierre anterior

12.146,00

Rango de hoy

11.984,00 – 12.210,00

Volumen hoy

2.234.951

Información
Nombre completo
AstraZeneca PLC
Divisa
GBp
Mercado
LSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
96.100
PER
24,35 (puede no estar actualizado)
Dividend yield
1,99% (puede no estar actualizado)
Precio objetivo analistas
15.757,64 GBp (puede no estar actualizado)
Primera cotización
21/05/1993
Precio actualizado
hace 2 días
Sobre la empresa

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Dividendos repartidos Total últimos 12 meses: 239,0000 GBp · Yield: 1,99%
Fecha de pago Importe por participación
03/08/2011 51,9000 GBp
02/02/2011 116,7000 GBp
04/08/2010 44,9000 GBp
03/02/2010 105,4000 GBp
05/08/2009 36,0000 GBp
04/02/2009 104,8000 GBp
06/08/2008 27,8000 GBp
06/02/2008 67,7000 GBp
08/08/2007 25,3000 GBp
07/02/2007 63,0000 GBp
09/08/2006 26,6000 GBp
08/02/2006 51,8000 GBp
10/08/2005 21,9000 GBp
09/02/2005 34,3000 GBp
11/08/2004 16,0000 GBp
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/04/2017 4.731,00 4.756,27 4.585,70 4.586,50 -3,30% 3,61% 2.887.043
13/04/2017 4.734,50 4.743,00 4.696,00 4.743,00 +0,18% 0,99% 1.844.895
12/04/2017 4.740,00 4.833,01 4.729,50 4.734,50 -0,22% 2,18% 1.512.895
11/04/2017 4.775,00 4.841,47 4.734,50 4.745,00 +0,15% 2,24% 1.920.542
10/04/2017 4.779,50 4.846,91 4.726,00 4.738,00 -1,16% 2,53% 1.841.398
07/04/2017 4.774,50 4.855,24 4.760,50 4.793,50 -0,03% 1,98% 2.171.075
06/04/2017 4.818,00 4.877,01 4.772,50 4.795,00 -1,29% 2,17% 2.123.849
05/04/2017 4.937,50 4.964,44 4.849,50 4.857,50 -1,97% 2,33% 2.482.511
04/04/2017 4.918,00 5.034,42 4.908,50 4.955,00 +0,92% 2,56% 2.779.515
03/04/2017 4.912,50 4.980,14 4.886,50 4.910,00 -0,05% 1,91% 2.447.273
31/03/2017 4.931,00 5.006,80 4.901,00 4.912,50 -0,29% 2,15% 2.287.390
30/03/2017 4.970,50 5.049,96 4.916,50 4.927,00 -0,56% 2,69% 1.696.461
29/03/2017 4.944,00 5.045,98 4.935,50 4.954,50 -0,11% 2,23% 1.768.597
28/03/2017 4.965,50 5.012,27 4.940,00 4.960,00 -0,29% 1,46% 2.100.864
27/03/2017 4.916,50 5.053,03 4.864,50 4.974,50 +0,93% 3,83% 2.043.529
24/03/2017 4.948,00 4.975,12 4.896,25 4.928,50 -0,63% 1,59% 1.667.736
23/03/2017 4.871,00 5.051,46 4.855,00 4.959,50 +2,21% 4,03% 3.049.287
22/03/2017 4.799,50 4.910,93 4.790,50 4.852,50 +0,54% 2,51% 1.969.612
21/03/2017 4.893,00 4.953,17 4.822,50 4.826,50 -1,50% 2,67% 2.222.127
20/03/2017 4.899,50 4.978,45 4.859,00 4.900,00 +0,06% 2,44% 1.337.141
17/03/2017 4.820,00 4.940,06 4.820,00 4.897,00 +0,64% 2,49% 4.469.010
16/03/2017 4.850,50 4.903,39 4.829,50 4.866,00 +0,33% 1,52% 2.294.572
15/03/2017 4.865,00 4.963,30 4.841,00 4.850,00 -0,09% 2,51% 2.629.244
14/03/2017 4.835,00 4.911,97 4.827,50 4.854,50 +0,82% 1,75% 2.216.997
13/03/2017 4.778,50 4.890,46 4.762,50 4.815,00 +1,17% 2,68% 2.595.417
10/03/2017 4.774,00 4.850,90 4.758,00 4.759,50 -0,10% 1,95% 2.059.505
09/03/2017 4.751,50 4.825,44 4.712,50 4.764,50 +0,19% 2,38% 1.723.294
08/03/2017 4.749,00 4.842,06 4.699,50 4.755,50 +0,83% 3,00% 3.083.578
07/03/2017 4.762,00 4.798,01 4.620,50 4.716,50 -0,96% 3,73% 1.976.976
06/03/2017 4.778,50 4.829,77 4.755,38 4.762,00 -0,39% 1,56% 1.236.910